Myeloma News: From Iceland to China

In this blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie highlights the IMF-funded iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) study on the prevalence of smoldering multiple myeloma (SMM) based on a nationwide screening of over 75,000 Icelandic individuals aged 40 and above. He also discusses the CAR T product GC012F from China receiving FDA clearance for its IND application. https://www.myeloma.org/blog/myeloma-news-from-iceland-china